Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 53

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 1
Chunk 53
---
ICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

products. Our product lines, as disclosed in Note 5: Revenue, were determined to be a single operating segment as discrete financial information by product-line is limited to revenue and standard cost. Other cost of sale expenses, which include above-site manufacturing costs, manufacturing variances and supply chain costs including freight and warehousing are not allocated to individual product lines. Similarly, quality, regulatory and other operating expenses are only provided to our chief operating decision maker ("CODM") at the consolidated level.For information on disaggregation of revenues by product-line and geography, see Note 5: Revenue.Our chief executive officer is our CODM. Our CODM uses net profit (loss) to manage our business activities on a consolidated basis and to evaluate and assess the performance of the Company when determining how to allocate capital resources. Our segment performance is monitored and resource allocation is determined during the consolidated annual budget/forecast processes. The measure of segment assets is reported on the consolidated balance sheets as total assets. Expenditures for additions to long-lived assets were $22.0 million and $38.9 million for the three and six months ended June 30, 2025 and $21.9 million and $40.7 million for the three and six months ended June 30, 2024, respectively. The following table presents information about our segment revenue, segment profit or loss, and significant segment expenses (in thousands):Three months ended June 30,Six months ended June 30,2025202420252024REVENUES$548,866 $596,455 $1,153,568 $1,163,110 Less:Standard COGS(1)249,816 298,429 543,224 581,430 Quality remediation/recall(2)5,706 3,924 15,686 11,422 Other COGS(3)85,280 86,674 176,485 177,586 Selling, general and administrative159,392 159,549 316,625 317,206 Research and development21,867 23,390 45,158 45,232 Restructuring and integration16,218 17,136 32,915 33,241 Other segment items(4)(46,157)238 (47,626)